Dali Pharmaceuticalco.,Ltd reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 86.41 million compared to CNY 132.33 million a year ago. Revenue was CNY 87.27 million compared to CNY 132.34 million a year ago.

Net loss was CNY 20.03 million compared to CNY 17.7 million a year ago. Basic loss per share from continuing operations was CNY 0.09 compared to CNY 0.08 a year ago. Diluted loss per share from continuing operations was CNY 0.09 compared to CNY 0.08 a year ago.